Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology

Journal of Clinical Pathology

Volumn 61, Issue 3, 2008, Pages 338-342

  Bayram, Aysen ^a   Erkilic, S ^a   Ozkur A ^a   Bayram, M ^a   Sari, I ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE MARKER; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM;

ADULT; AUTOANTIBODIES; BIOPSY; CHI-SQUARE DISTRIBUTION; DNA, VIRAL; FEMALE; FIBROSIS; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; NECROSIS; PROGNOSIS; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 40449111261     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.050765     Document Type: Article

References (26)

1. World Health Organization. Hepatitis B. Morbidity and Mortality Weekly Report fact sheet no. 204. Geneva: World Health Organization, 2000.
2. Yuen M-F, Ng I O-L, Fan S-T, et al. Significance of HBV DNA levels in liver histology of HBeAg and anti-HBe positive patients. Am J Gastroenterol 2004;99:2032-7.
3. Yuen MF, Lai CL. Debates in hepatitis: how to assess HBV DNA reductions in association with therapy. Viral Hepatitis Rev 1999;5:159-75.
4. Olioso D, Boaretti M, Ligozzi M, et al. Detection and quantification of hepatitis B virus DNA by SYBR green real-time polymerase chain reaction. Eur J Clin Microbiol Infect Dis 2007;26:43-50.
5. Germer JJ, Qutub MO, Mandrekar JN, et al. Quantification of hepatitis B virus (HBV) DNA with a TaqMan HBV analyte-specific reagent following sample processing with the MagNA pure LC instrument. J Clin Microbiol 2006;44:1490-4.
6. Ronsin C, Pillet A, Bali C, et al. Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay. J Clin Microbiol 2006;44:1390-9.
7. Konnick EQ, Erali M, Ashwood ER, et al. Evaluation of the COBAS amplicor HBV monitor assay and comparison with the ultrasensitive HBV hybrid capture 2 assay for quantification of hepatitis B virus DNA. J Clin Microbiol 2005;43:596-603.
8. Singh M, Dicaire A, Wakil AE, et al. Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR. J Virol Methods 2004;118:159-67.
9. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
10. Zhu R, Huang H, Zhang H, et al. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels. Liver Int 2006;26:82-9.
11. Umeda M, Marusawa H, Seno H, et al. Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers. J Hepatol 2005;42:806-12.
12. Alberti A. Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B? Hepatology 2003;38:18-20.
13. Laras A, Koskinas J, Dimou E, et al. Intrahepatic levels and replicative activity of covalently closed circular Hepatitis B virus DNA in chronically infected patients. Hepatology 2006;44:694-702.
14. Sung JJ, Wong ML, Bowden S, et al. Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. Gastroenterology 2005;128:1890-7.
15. Chien R-N, Liaw Y-F, Atkins M. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Hepatology 1999;30:770-4.
16. Perrillo RP, Lai C-L, Liaw YF, et al. Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology 2002;36:186-94.
17. Bourne EJ, Dienstag JL, Lopez, et al. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy. J Viral Hepat 2007;14:55-63.
18. Wong DK-H, Yuen M-F, Yuan HJ, et al. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients. Hepatology 2004;40:727-37.
19. Wong DK-H, Yuen M-F, Tse E, et al. Detection of intrahepatic hepatitis B virus DNA and correlation with hepatic necroinflammation and fibrosis. J Clin Microbiol 2004;42:3920-4.
20. Mishiro T, Hamamoto S, Furuta K, et al. Quantitative measurement of hepatitis B virus DNA in different areas of hepatic lobules in patients with chronic hepatitis B. J Med Virol 2006;78:37-43.
21. Lee CZ, Huang GT, Yang PM, et al. Correlation of HBV DNA levels in serum and liver of chronic hepatitis B patients with cirrhosis. Liver 2002;22:130-5.
22. Chan HL-Y, Tsang SW-C, Liew C-T, et al. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection. Am J Gastroenterol 2002;97:406-12.
23. Nabuco LC, Villela-Nogueira CA, Perez RM, et al. HBV-DNA levels in HBsAg-positive blood donors and its relationship with liver histology. J Clin Gastroenterol 2007;41:194-8.
24. Lindh M, Horal P, Dhillon AP, et al. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 2000;7:258-67.
25. Zavaglia C, Mondazzi L, Maggi G, et al. Are alanine aminotransferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B? Liver 1997;17:83-7.
26. Yuen M-F, Tanaka Y, Ng IO-L, et al. Hepatic necroinflammation and fibrosis in patients with genotypes Ba and C, core-promoter and precore mutations. J Viral Hepat 2005;12:513-8.